InvestSMART

Nova Eye Medical Limited (ASX: EYE) - Announcements

- Current share price for EYE : $0.145

ASX company news and announcements for Nova Eye Medical Limited (EYE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Nova Eye Medical Limited (EYE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Nova Eye Medical Limited (EYE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Nova Eye Medical Limited (EYE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$41 IDE Application for 2RT filed with the FDA 5 Jul 2021 10:24AM $0.330 $0.145 fallen by 56.06%
$41 2RT to be Featured at the 2021 Meeting of ARVO 3 May 2021 8:05AM $0.330 $0.145 fallen by 56.06%
$41 Change in substantial holding from AEF 30 Apr 2021 8:40AM $0.320 $0.145 fallen by 54.69%
$41 First Patient enrolled in MAGIC Clinical Trial 30 Apr 2021 8:07AM $0.320 $0.145 fallen by 54.69%
$41 2RT Post LEAD Review Shows Improved Treatment Benefits 5 Mar 2021 8:32AM $0.330 $0.145 fallen by 56.06%
$41 Clinical trial to Assess Efficacy and Safety of i Track 2 Mar 2021 8:40AM $0.340 $0.145 fallen by 57.35%
$41 Investor presentation Half year Results 31 December 2020 25 Feb 2021 8:29AM $0.330 $0.145 fallen by 56.06%
$41 Half Year Results Discussion 25 Feb 2021 8:28AM $0.330 $0.145 fallen by 56.06%
$41 Half Year Accounts 25 Feb 2021 8:24AM $0.330 $0.145 fallen by 56.06%
$41 Notice of Upcoming Investor Call 18 Feb 2021 3:26PM $0.340 $0.145 fallen by 57.35%
$41 Change in substantial holding from AEF 14 Dec 2020 6:57PM $0.335 $0.145 fallen by 56.72%
$41 Appendix 2A Conversion of Performance Rights 9 Dec 2020 12:20PM $0.340 $0.145 fallen by 57.35%
$41 Appendix 3G Issue of Options and Performance Rights 9 Dec 2020 11:51AM $0.340 $0.145 fallen by 57.35%
$41 AGM Poll Results 27 Nov 2020 5:16PM $0.360 $0.145 fallen by 59.72%
$41 AGM Chairman's Address 27 Nov 2020 5:16PM $0.360 $0.145 fallen by 59.72%
$41 AGM presentation and update 27 Nov 2020 5:14PM $0.360 $0.145 fallen by 59.72%
$41 Sales Update 25 Nov 2020 1:49PM $0.340 $0.145 fallen by 57.35%
$41 2RT Clinical Update 16 Nov 2020 9:26AM $0.345 $0.145 fallen by 57.97%
$41 Establishment of AlpaRET 26 Oct 2020 9:15AM $0.325 $0.145 fallen by 55.38%
$41 Notice of Annual General Meeting/Proxy Form 26 Oct 2020 9:12AM $0.325 $0.145 fallen by 55.38%
$41 AGM date and Director Nomnations 8 Oct 2020 1:05PM $0.320 $0.145 fallen by 54.69%
$41 Date of AGM and Director Nominations 8 Oct 2020 10:03AM $0.325 $0.145 fallen by 55.38%
$41 Appendix 03Y Mr T Spurling 25 Sep 2020 2:24PM $0.330 $0.145 fallen by 56.06%
$41 Change in Substantial Holding from AEF 18 Sep 2020 12:07PM $0.340 $0.145 fallen by 57.35%
$41 Change in Substantial Holding from AEF 10 Sep 2020 1:35PM $0.310 $0.145 fallen by 53.23%

251 - 275 of 352 results

Page 11 of 15

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.